A critical function for CD200 in lung immune homeostasis and the severity of influenza infection

Nature Immunology

Volumn 9, Issue 9, 2008, Pages 1074-1083

  Snelgrove, Robert J ^a   Goulding, John ^a   Didierlaurent, Arnaud M ^a   Lyonga, Daphne ^a   Vekaria, Seema ^a   Edwards, Lorna ^a   Gwyer, Emily ^a   Sedgwick, Jonathon D ^b   Barclay, A Neil ^c   Hussell, Tracy ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b ELI LILLY AND COMPANY   (United States)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD200 ANTIGEN; CD200 RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BONE MARROW CELL; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; IMMUNE RESPONSE; IMMUNOREGULATION; INFECTION SENSITIVITY; INFLUENZA; LUNG ALVEOLUS MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RESPIRATORY EPITHELIUM; RESPIRATORY TRACT INFLAMMATION;

ANIMALS; CERAMICS; CYTOKINES; HOMEOSTASIS; HUMANS; INFLUENZA, HUMAN; LUNG; MICE; MYELOID CELLS;

EID: 50049100345     PISSN: 15292908     EISSN: 15292916     Source Type: Journal    
DOI: 10.1038/ni.1637     Document Type: Article

References (56)

1. Raz, E. Organ-specific regulation of innate immunity. Nat. Immunol. 8, 3-4 (2007).
2. Matzinger, P. Friendly and dangerous signals: Is the tissue in control? Nat. Immunol. 8, 11-13 (2007).
3. Bingisser, R.M. & Holt, P.G. Immunomodulating mechanisms in the lower respiratory-tract: Nitric oxide mediated interactions between alveolar macrophages, epithelial cells, and T-cels. Swiss Med. Wkly. 131 171-179 (2001).
4. 6 binds and activates latent TGF-β1: A mechanism for regulating pulmonary inflammation and fibrosis. Cell 96, 319-328 (1999).
5. Takabayshi, K. et al. Induction of a homeostatic circuit in lung tissue by microbial compounds. Immunity 24, 475-487 (2006).
6. 6-mediated TGF-β activation causes Mmp12-dependent emphysema. Nature 422, 169-173 (2003).
7. Wright, G.J. et al. Lymphoid/neuronal cell surface OX2 glycoprotein recognizes a novel receptor on macrophages implicated in the control of their function. Immunity 13, 233-242 (2000).
8. Wright, G.J. et al. Characterization of the CD200 receptor family in mice and humans and their interactions with CD200. J. Immunol. 171, 3034-3046 (2003).
9. Zhang, S., Cherwinski, H., Sedgwick, J.D. & Phillips, J.H. Molecular mechanisms of CD200 inhibition of mast cell activation. J. Immunol. 173, 6786-6793 (2004).
10. Cherwinski, H.M. et al. The CD200 receptor is a novel and potent regulator of murine and human mast cell function. J. Immunol. 174, 1348-1356 (2005).
11. Shiratori, I. et al. Down-regulation of basophil function by human CD200 and human herpesvirus-8 CD200. J. Immunol. 175, 4441-4449 (2005).
12. Barclay, A.N. & Ward, H.A. Purification and chemical characterisation of membrane glycoproteins from rat thymocytes and brain, recognised by monoclonal antibody MRC OX 2. Eur. J. Biochem. 129, 447-458 (1982).
13. Hoek, R.M. et al. Down-regulation of the macrophage lineage through interaction with OX2 (CD200). Science 290, 1768-1771 (2000).
14. Wright, G.J., Jones, M., Puklavec, M.J., Brown, M.H. & Barclay, A.N. The unusual distribution of the neuronal/lymphoid cell surface CD200 (OX2) glycoprotein is conserved in humans. Immunology 102, 173-179 (2001).
15. Webb, M. & Barclay, A.N. Localisation of the MRC OX-2 glycoprotein on the surfaces of neurones. J. Neurochem. 43, 1061-1067 (1984).
16. Dick, A.D., Broderick, C., Forrester, J.V. & Wright, G.J. Distribution of OX2 antigen and OX2 receptor within retina. Invest. Ophthalmol. Vis. Sci. 42, 170-176 (2001).
17. Bukovsky, A., Presl, J. & Zidovsky, J. Association of some cell surface antigens of lymphoid cells and cell surface differentiation antigens with early rat pregnancy. Immunology 52, 631-640 (1984).
18. Nathan, C. & Muller, W.A. Putting the brakes on innate immunity: A regulatory role for CD200? Nat. Immunol. 2, 17-19 (2001).
19. Chen, Z., Zeng, H. & Gorczynski, R.M. Cloning and characterization of the murine homologue of the rat/human MRC OX-2 gene. Biochim. Biophys. Acta 1362, 6-10 (1997).
20. McCaughan, G.W., Clark, M.J. & Barclay, A.N. Characterization of the human homolog of the rat MRC OX-2 membrane glycoprotein. Immunogenetics 25, 329-335 (1987).
21. de Heer, H.J., Hammad, H., Kool, M. & Lambrecht, B.N. Dendritic cell subsets and immune regulation in the lung. Semin. Immunol. 17 295-303 (2005).
22. Fernandez, S., Jose, P., Avdiushko, M.G., Kaplan, A.M. & Cohen, D.A. Inhibition of IL-10 receptor function in alveolar macrophages by Toll-like receptor agonists. J. Immunol. 172, 2613-2620 (2004).
23. Tuthill, T.J. et al. Mouse respiratory epithelial cells support efficient replication of human rhinovirus. J. Gen. Virol. 84 2829-2836 (2003).
24. Gardai, S.J. et al. By binding SIRPα or calreticulin/CD91, lung collectins act as dual function surveillance molecules to suppress or enhance inflammation. Cell 115, 13-23 (2003).
25. Mestecky, J., Russell, M.W. & Elson, C.O. Perspectives on mucosal vaccines: Is mucosal tolerance a barrier? J. Immunol. 179, 5633-5638 (2007).
26. Kong, X.N. et al. LPS-induced down-regulation of signal regulatory protein α contributes to innate immune activation in macrophages. J. Exp. Med. 204, 2719-2731 (2007).
27. Liew, F.Y., Xu, D., Brint, E.K. & O'Neill, L.A. Negative regulation of Toll-like receptor-mediated immune responses. Nat. Rev. Immunol. 5, 446-458 (2005).
28. Han, J. & Ulevitch, R.J. Limiting inflammatory responses during activation of innate immunity. Nat. Immunol. 6, 1198-1205 (2005).
29. Carmody, R.J., Ruan, Q., Palmer, S., Hilliard, B. & Chen, Y.H. Negative regulation of Toll-like receptor signaling by NF-κB p50 ubiquitination blockade. Science 317, 675-678 (2007).
30. Broderick, C. et al. Constitutive retinal CD200 expression regulates resident microglia and activation state of inflammatory cells during experimental autoimmune uveoretinitis. Am. J. Pathol. 161, 1669-1677 (2002).
31. Taylor, N. et al. Enhanced tolerance to autoimmune uveitis in CD200-deficient mice correlates with a pronounced Th2 switch in response to antigen challenge. J. Immunol. 174, 143-154 (2005).
32. Copland, D.A. et al. Monoclonal antibody-mediated CD200 receptor signaling suppresses macrophage activation and tissue damage in experimental autoimmune uveoretinitis. Am. J. Pathol. 171, 580-588 (2007).
33. Banerjee, D. & Dick, A.D. Blocking CD200-CD200 receptor axis augments NOS-2 expression and aggravates experimental autoimmune uveoretinitis in Lewis rats. Ocul. Immunol. Inflamm. 12, 115-125 (2004).
34. Karupiah, G., Chen, J.H., Mahalingam, S., Nathan, C.F. & MacMicking, J.D. Rapid interferon γ-dependent clearance of influenza A virus and protection from consolidating pneumonitis in nitric oxide synthase 2-deficient mice. J. Exp. Med. 188, 1541-1546 (1998).
35. Akaike, T. Role of free radicals in viral pathogenesis and mutation. Rev. Med. Virol. 11, 87-101 (2001).
36. Akaike, T. et al. Pathogenesis of influenza virus-induced pneumonia: Involvement of both nitric oxide and oxygen radicals. Proc. Natl. Acad. Sci. USA 93, 2448-2453 (1996).
37. Snelgrove, R.J., Edwards, L., Rae, A.J. & Hussell, T. An absence of reactive oxygen species improves the resolution of lung influenza infection. Eur. J. Immunol. 36, 1364-1373 (2006).
38. Hussell, T., Pennycook, A. & Openshaw, P.J, Inhibition of tumor necrosis factor reduces the severity of virus-specific lung immunopathology. Eur. J. Immunol. 31, 2566-2573 (2001).
39. Peper, R.L. & Van Campen, H. Tumor necrosis factor as a mediator of inflammation in influenza A viral pneumonia. Microb. Pathog. 19 175-183 (1995).
40. Cook, D.N. et al. Requirement of MIP-1 α for an inflammatory response to viral infection. Science 269, 1583-1585 (1995).
41. Snelgrove, R.J., Edwards, L., Williams, A.E., Rae, A.J. & Hussell, T. In the absence of reactive oxygen species, T cells default to a Th1 phenotype and mediate protection against pulmonary Cryptococcus neoformans infection. J. Immunol. 177, 5509-5516 (2006).
42. Lawrence, T., Gilroy, D.W., Colville-Nash, P.R. & Willoughby, D.A. Possible new role for NF-ΚB in the resolution of inflammation. Nat. Med. 7, 1291-1297 (2001).
43. Barclay, A.N., Wright, G.J., Brooke, G. & Brown, M.H. CD200 and membrane protein interactions in the control of myeloid cells. Trends Immunol. 23, 285-290 (2002).
44. Dong, K.K. et al. Adaptive immune cells temper initial innate responses. Nat. Med. 13, 1248-1252 (2007).
45. Rosenblum, M.D. et al. CD200 is a novel p53-target gene involved in apoptosis-associated immune tolerance. Blood 103, 2691-2698 (2004).
46. Gorczynski, R.M., Chen, Z., Yu, K. & Hu, J. CD200 immunoadhesin suppresses collagen-induced arthritis in mice. Clin. Immunol. 101, 328-334 (2001).
47. Gorczynski, R.M., Chen, Z., Lee, L., Yu, K. & Hu, J. Anti-CD200R ameliorates collagen-induced arthritis in mice. Clin. Immunol. 104, 256-264 (2002).
48. Gorczynski, R.M. et al. An immunoadhesin incorporating the molecule OX-2 isa potent immunosuppressant that prolongs allo- and xenograft survival. J. Immunol. 163, 1654-1660 (1999).
49. Lipatov, A.S. et al. Pathogenesis of Hong Kong H5N1 influenza virus NS gene reassortants in mice: The role of cytokines and B- and T-cell responses. J. Gen. Virol. 86, 1121-1130 (2005).
50. Chan, M.C. et al. Proinflammatory cytokine responses induced by influenza A (H5N1) viruses in primary human alveolar and bronchial epithelial cells. Respir. Res. 6, 135 (2005).
51. de Jong, M.D. et al. Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat. Med. 12, 1203-1207 (2006).
52. Peiris, J.S. et al. Re-emergence of fatal human influenza A subtype H5N1 disease. Lancet 363, 617-619 (2004).
53. Boudakov, I. et al. Mice lacking CD200R1 show absence of suppression of lipopolysaccharide-induced tumor necrosis factor-α and mixed leukocyte culture responses by CD200. Transplantation 84 251-257 (2007).
54. - thymocytes with specific lymphokine secretion. Eur. J. Immunol. 23, 307-310 (1993).
55. Hussell, T., Spender, L.C., Georgiou, A., O'Garra, A. & Openshaw, P.J.M. Th1 and Th2 cytokine induction in pulmonary T-cells during infection with respiratory syncytial virus. J. Gen. Virol. 77, 2447-2455 (1996).
56. Corti, M., Brody, A.R. & Harrison, J.H. Isolation and primary culture of murine alveolar type II cells. Am. J. Respir. Cell Mol. Biol. 14, 309-315 (1996).